Presentation TCT 2023 TCT 659: De-escalation of antiplatelet therapy in elderly or low-weight patients with myocardial infarction. Presenter: Hyunki LEE October 25, 2023 REGISTER for free or LOG IN to view this content Coronary TCT 2023 Up Next Presentation TCT 2023 TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis Presenter: Aakash Garg October 25, 2023 More slides + Presentation TCT 2023 TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing Percutaneous Coronary Intervention: A Nationwide, Retrospective, Population-based Study Using National Health Insurance Data… Presenter: Young-Hoon Seo October 25, 2023 Presentation TCT 2023 TCT 160: Comparative Effectiveness of Moderate-intensity Statin with Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study Presenter: Ji-Yong Jang October 25, 2023 We Recommend Disclosures NULL
Presentation TCT 2023 TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis Presenter: Aakash Garg October 25, 2023
Presentation TCT 2023 TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing Percutaneous Coronary Intervention: A Nationwide, Retrospective, Population-based Study Using National Health Insurance Data… Presenter: Young-Hoon Seo October 25, 2023
Presentation TCT 2023 TCT 160: Comparative Effectiveness of Moderate-intensity Statin with Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study Presenter: Ji-Yong Jang October 25, 2023